Fierce Pharma Marketing

Heart disease has held the top spot as the world’s #1 killer for decades — but that may be about to change. ❤️🔥 In this fireside chat, Dr. Benjamin Oakes, CEO of Scribe Therapeutics Therapeutics, joins Frasier Kansteiner from Fierce Pharma for a bold discussion on how CRISPR could move us from managing disease to preventing it altogether. They’ll dig into what it really takes to make genetic prevention a reality — from rethinking healthcare economics to tackling the delivery and safety challenges of bringing CRISPR to widespread conditions like cardiovascular disease. This is the kind of conversation that makes you stop and think: if we can rewrite our genes, can we rewrite the future of human health? Register now for this Complimentary Virtual Event: https://loom.ly/aEmQgMw #FierceBiotech #WeAreFierce #CellandGeneTherapy #BiotechEvents

After years of explosive growth, gene and cell therapies are hitting a critical crossroads — and the money questions can’t be ignored. 💸 With investors tightening their grip and valuations in flux, what does the next wave of funding really look like for advanced therapies? Join Sravan Emany (Beam Therapeutics), William Ho Ho (IN8bio), Esta Caffarel (Chiesi Group), and Andrew Lam (Ally Bridge Group) as they pull back the curtain on what’s driving confidence (or concern) in the market. Moderated by Kevin Dunleavy at Fierce Pharma, this candid conversation will cut through the noise and tackle the uncomfortable—but necessary—truths about where the field goes from here. Register now for this Complimentary Virtual Event: https://loom.ly/aEmQgMw #FierceBiotech #WeAreFierce #CellandGeneTherapy #BiotechEvents

Big changes are coming to the regulatory landscape — and this panel is going to unpack what it really means for the future of cell and gene therapies. ⚡ With the FDA signaling faster, more flexible pathways under new leadership, the industry is watching closely to see whether this will truly accelerate innovation or simply raise new questions. Join Amber Salzman, PhD (Epicrispr Biotechnologies), Lynelle Hoch (Bristol Myers Squibb), Fabian Gerlinghaus (Cellares), and Timothy Hunt (Alliance for Regenerative Medicine) for a candid conversation moderated by Angus Liu of Fierce Biotech. Expect unfiltered insights on how these changes could reshape development timelines, partnerships, and patient access — and why staying ahead of the FDA’s next move might be your biggest competitive advantage. Register now for this Complimentary Virtual Event: https://loom.ly/aEmQgMw #FierceBiotech #WeAreFierce #CellandGeneTherapy #BiotechEvents

We're proud to partner with organizations that value true collaboration. Thank you to the Impiricus team for sharing their experience at hashtag #FPW. ✅ Let's Talk 2026 Partnerships: https://loom.ly/oIgm8aA Join the companies shaping the future of pharma. As a Fierce Pharma Week partner, you’ll gain premium visibility, strategic networking opportunities, and support from a team committed to elevating your brand. 2026 planning is in progress and we would love to talk to you today to see how we can help your goals. ✅ Let's Talk Partnerships: https://loom.ly/oIgm8aA #FiercePharmaWeek #PharmaEvents

Patent cliffs worth hundreds of billions are driving a new wave of transformative deal-making. At Fierce JPM Week 2026, industry leaders will dissect the strategies behind pharma’s boldest acquisitions and explore whether aggressive portfolio building can stabilize growth in an era of uncertainty. 💬 Panel: Pharma’s Big Bets and the Resurgence of M&A 🕓 Tuesday, Jan 13 | 9:20–10:00 AM 📍 San Francisco | Fierce JPM Week 2026 🔗 Register now and save $600: fiercejpmweek.com #FierceJPMWeek #JPM2026 #Pharma #M&A #LifeSciences #TheGreatReset

Questex Strengthens Leadership in the $88.2B Life Sciences Industry with Strategic Acquisitions We’re thrilled to announce that Questex has acquired The Conference Forum and Versalinx Global Events which are two industry leaders in life sciences conferences and intelligence. The life sciences market is thriving, projected to grow from $88.2 billion in 2024 to $269.56 billion by 2034 (12% CAGR). This move further solidifies Questex’s position as a powerhouse across the healthcare and life sciences ecosystem. Together, these additions enhance the Fierce Healthcare & Life Sciences platform, creating more opportunities for learning, networking, and meaningful business growth. Learn more about Questex’s growing portfolio: https://loom.ly/eCH2WWo

After years of scientific advances and ramped-up investment in cell and gene therapies, enthusiasm in the field has been tempered on the heels of high-profile setbacks. But the clinical promise of these therapies is undeniable. Where will the industry go from here? Don't miss Fierce Biotech’s virtual event on November 20th for an up-to-date, realistic look at the field of advanced therapies. Register Now https://loom.ly/xRN2AOI #FierceBiotech #WeAreFierce #CellandGeneTherapy #BiotechEvents

Tap Into the Power of Sound in Pharma Marketing Pharma planning season is the moment to think bigger and we see brands going bigger into audio for reach extension, storytelling, creative flexibility and as a cultural amplifier. Check out 5 audio trends shaping the audio pharma marketing for the year to come. https://lnkd.in/e8ap2mGe

So proud of our team at Acadia Pharmaceuticals Inc. and our amazing partners at Lippe Taylor! Winning the Influencer-Driven category at the 2025 Fierce Pharma Marketing Awards is such a meaningful recognition of our More to Parkinson's campaign. This award reflects the creativity, collaboration, and commitment of so many colleagues who worked tirelessly to bring an authentic patient and caregiver voice forward to increase awareness of Parkinson's related hallucinations and delusions. Congratulations to everyone who contributed to this achievement—we did this together! Carolyn Hobbs; Deb Kazenelson Deane; Jennifer J. Rhodes; Siobhan Cullen; Jane Wright-Mitchell; Alyssa Ciambriello; Jennifer Gauthier; Lambros Chrones, MD; Stanley Nam; Matt Murphy, III; Amit Patel; Stephanie Kim; Tom Garner and many others!! www.MoretoParkinsons.com

Congratulations to GILDEAD and Inizio for winning the Public Relations category! We’re thrilled to recognize them as the 2025 Fierce Pharma Marketing Awards Winner 🏆 View all winners here: https://loom.ly/WQVeZ7E The Fierce Pharma Marketing Awards honor the most creative, strategic, and impactful campaigns across the life sciences industry. These awards celebrate the teams and individuals setting the standard for excellence in pharma marketing. Stay tuned for 2026 Fierce Pharma Marketing Awards announcements which is your chance to showcase the next wave of groundbreaking campaigns. https://loom.ly/9QDiGa4 #FiercePharmaMarketingAwards #FPMA2025 #FiercePharma #PharmaMarketing